Ładuje się......
Lymphoblastic Cell Lines in Pharmacogenomics: How applicable are they in clinical outcomes?
LCLs are widely used in pharmacogenomic studies and the applicability of LCLs for various clinical phenotypes is emerging. Early studies have yielded promising results for LCLs as a proxy for genetic variants for treatment outcome for a number of cancers as well as toxicity in varying tissue types i...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4075127/ https://ncbi.nlm.nih.gov/pubmed/23556440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.13.32 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|